McCreadie Group Innovative Solutions for Pharmacy

Investigational Drug Service Software, Vestigo®, Selected by MedStar Georgetown University Hospital

McCreadie Group, Inc.


Contact: Kim Zurawski


Investigational Drug Service Software, Vestigo®, Selected by MedStar Georgetown University Hospital

Pharmacy software company’s web-based solution chosen by Washington D.C. healthcare leader to enhance IDS efficiencies and safety. 

JUNE 18, 2015 – ANN ARBOR, MICH. – McCreadie Group, Inc., a privately held pharmacy software solutions provider headquartered in Ann Arbor, Mich., is pleased to announce MedStar Georgetown University Hospital’s decision to implement its web-based Investigational Drug Service (IDS) product, Vestigo®.

Launched in 2005, Vestigo eliminates many of the manual steps involved in IDS operations. It has set the industry standard for IDS automation by significantly enhancing efficiencies while helping ensure that complex protocols are properly managed for consistency, safety and compliance. Vestigo is used by many of the country’s top research institutions, as well as several smaller research pharmacies.

Because it greatly reduces the manual steps and paperwork involved in the IDS operation, Vestigo adds accuracy and efficiencies to protocol management, inventory control, dispensing and labeling, billing, accountability reporting, monitor activities and  scheduling.

Attention was recently drawn to the principles and practices of IDS by the Hematology / Oncology Pharmacy Association (HOPA) Best Practice Standards, published in the fall of last year. The standards apply to any clinical research involving medications. HOPA recommends the use of computer software for investigational medication management.

“Vestigo has a ten-year track record of supporting the needs of IDS operations across the country to improve efficiencies and safeguard protocols,” said Scott McCreadie, PharmD, MBA, founder and president of McCreadie Group. “MedStar Georgetown University Hospital is well known for its progressive research and adoption of cutting-edge technologies. We are thrilled to have them join our growing list of prestigious clients.”

Vestigo is used by 45 percent of the 2014 U.S. News & World Report’s top-ranked hospitals for cancer, as well as 45 percent of all National Cancer Institute (NCI)-designated cancer centers and 70 percent of the top National Institutes of Health (NIH)-funded research institutions.

About McCreadie Group

The McCreadie Group, Inc. was founded in 2004 to provide software solutions for pharmacy applications in healthcare, research and educational settings. Our goal is to drive improvements in quality, efficiency, safety and compliance in the pharmacy profession by delivering innovative software and consultative support. To learn more about McCreadie Group and its products, visit